These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3661612)

  • 1. Effects of concurrent sucralfate administration on pharmacokinetics of naproxen.
    Caille G; du Souich P; Gervais P; Besner JG; Vezina M
    Am J Med; 1987 Sep; 83(3B):67-73. PubMed ID: 3661612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of food and sucralfate on the pharmacokinetics of naproxen and ketoprofen in humans.
    Caillé G; du Souich P; Besner JG; Gervais P; Vézina M
    Am J Med; 1989 Jun; 86(6A):38-44. PubMed ID: 2735334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose pharmacokinetics of ketoprofen, indomethacin, and naproxen taken alone or with sucralfate.
    Caillé G; Du Souich P; Gervais P; Besner JG
    Biopharm Drug Dispos; 1987; 8(2):173-83. PubMed ID: 3593897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of chewable sucralfate or a standard meal on the bioavailability of naproxen.
    Lafontaine D; Mailhot C; Vermeulen M; Bissonnette B; Lambert C
    Clin Pharm; 1990 Oct; 9(10):773-7. PubMed ID: 2242657
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of concurrent sucralfate administration on the absorption of erythromycin.
    Miller LG; Prichard JG; White CA; Vytla B; Feldman S; Bowman RC
    J Clin Pharmacol; 1990 Jan; 30(1):39-44. PubMed ID: 2303579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.
    Kamberi M; Nakashima H; Ogawa K; Oda N; Nakano S
    Br J Clin Pharmacol; 2000 Feb; 49(2):98-103. PubMed ID: 10671902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sucralfate on the absorption and pharmacokinetics of chlorpropamide.
    Letendre PW; Carlson JD; Seifert RD; Dietz AJ; Dimmit D
    J Clin Pharmacol; 1986; 26(8):622-5. PubMed ID: 3793953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
    KuKanich K; KuKanich B; Guess S; Heinrich E
    J Vet Intern Med; 2016; 30(1):108-15. PubMed ID: 26651022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiple-dose pharmacokinetic comparison of naproxen as a once-daily controlled-release tablet and a twice-daily conventional tablet.
    Ling TL; Yee JP; Cohen A; Hsiao C; Gonzalez MA; Garg DC; Weidler DJ
    J Clin Pharmacol; 1987 Apr; 27(4):325-9. PubMed ID: 3680592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.
    Stass H; Schühly U; Möller JG; Delesen H
    Clin Pharmacokinet; 2001; 40 Suppl 1():49-55. PubMed ID: 11352442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sucralfate on absorption of norfloxacin and ofloxacin.
    Lehto P; Kivistö KT
    Antimicrob Agents Chemother; 1994 Feb; 38(2):248-51. PubMed ID: 8192452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers.
    Awni WM; Braeckman RA; Cavanaugh JH; Locke CS; Linnen PJ; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():112-24. PubMed ID: 8620667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
    Choi Y; Han H; Shin D; Lim KS; Yu KS
    Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers.
    Lubowski TJ; Nightingale CH; Sweeney K; Quintiliani R
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2758-60. PubMed ID: 1482143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
    Wang-Smith L; Fort J; Zhang Y; Sostek M
    J Clin Pharmacol; 2012 May; 52(5):670-80. PubMed ID: 21628602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sucralfate on theophylline absorption in healthy volunteers.
    Cantral KA; Schaaf LJ; Jungnickel PW; Monsour HP
    Clin Pharm; 1988 Jan; 7(1):58-61. PubMed ID: 3345643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo interaction of ketoconazole and sucralfate in healthy volunteers.
    Carver PL; Berardi RR; Knapp MJ; Rider JM; Kauffman CA; Bradley SF; Atassi M
    Antimicrob Agents Chemother; 1994 Feb; 38(2):326-9. PubMed ID: 7910724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sucralfate on trilisate bioavailability.
    Schneider DK; Gannon RH; Sweeney KR; DeFusco PA
    J Clin Pharmacol; 1991 Apr; 31(4):377-9. PubMed ID: 2037712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.